POET Technologies Inc. (POET) is down 14.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The stock appears to be extending a selloff after the company disclosed that all purchase orders tied to Celestial AI (now part of Marvell) were cancelled. The cancellation increases uncertainty around near-term commercialization timelines and has likely amplified risk concerns around customer concentration and potential financing needs.
Details:
Sources:
POET Technologies, GlobeNewswire, Simply Wall St
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$POET Hedge Fund Activity
We have seen 63 institutional investors add shares of $POET stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MMCAP INTERNATIONAL INC. SPC removed 2,059,035 shares (-57.4%) from their portfolio in Q4 2025, for an estimated $13,033,691
- MORGAN STANLEY added 857,574 shares (+236.5%) to their portfolio in Q4 2025, for an estimated $5,428,443
- CITADEL ADVISORS LLC added 678,216 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,293,107
- PRIVATE ADVISOR GROUP, LLC removed 412,246 shares (-96.4%) from their portfolio in Q1 2026, for an estimated $2,448,741
- JANE STREET GROUP, LLC added 323,667 shares (+1239.7%) to their portfolio in Q4 2025, for an estimated $2,048,812
- TWO SIGMA INVESTMENTS, LP added 305,639 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,934,694
- RAYMOND JAMES FINANCIAL INC added 275,684 shares (+66.7%) to their portfolio in Q4 2025, for an estimated $1,745,079
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.